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Review
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INTRODUCTION
The technique of fat grafting was first used by Neuber in 1893 
and later evolved as a method to repair soft tissue defects [1]. 
This minimally invasive procedure increases soft tissue volume 
with minimal trauma, rapid recovery and immediate results. 
Over the years, the unpredictable reabsorption, formation of 
calcifications and potential risk of inducing malignancy lead to 
some concerns and a decline in its usage [1]. However, in the 
last two decades, despite these concerns, fat grafting has become 
a valuable resource in the plastic surgeon’s armamentarium not 
only to provide soft tissue volume but also to regenerate dam-
aged tissue by taking advantage of the mesenchymal stem cell 
population within the graft [2,3]. 
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As the popularity of fat grafting research increases, animal models are being used as the 
source of pre-clinical experimental information for discovery and to enhance techniques. To 
date, animal models used in this research have not been compared to provide a standardized 
model. We analyzed publications from 1968–2015 to compare published accounts of animal 
models in fat grafting research. Data collected included: species used, graft characteristics 
(donor tissue, recipient area, amount injected, injection technique), time of sacrifice and 
quantification methods.  Mice were most commonly used (56% of studies), with the “athymic 
nude” strain utilized most frequently (44%). Autologous fat was the most common source of 
grafted tissue (52%). Subcutaneous dorsum was the most common recipient site (51%). On 
average, 0.80±0.60 mL of fat was grafted. A single bolus technique was used in 57% of 
studies. Fat volume assessment was typically completed at the end of the study, occurring at 
less than 1 week to one year. Graft volume was quantified by weight (63%), usually in 
conjunction with another analysis. The results demonstrate the current heterogeneity of 
animal models in this research. We propose that the research community reach a consensus 
to allow better comparison of techniques and results. One example is the model used in our 
laboratory and others; this model is described in detail. Eventually, larger animal models may 
better translate to the human condition but, given increased financial costs and animal 
facility capability, should be explored when data obtained from small animal studies is 
exhausted or inconclusive.
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While the majority of investigations are showing fat grafting to 
be safe from an oncologic perspective over the available periods 
of study [4,5], the optimal technique for the procedure has not 
been established. There are currently no gold standards for ad-
dressing harvesting, processing, re-injecting and recipient site 
specifications to achieve long-lasting and predictable results [6]. 
As the prevalence of fat grafting increases in both cosmetic and 
reconstructive surgery (either as low-volume or high-volume fat 
grafting), it is crucial that techniques are optimized. Scientific 
innovation is the pathway to the best procedural methods which 
is paramount to the future of fat grafting in plastic surgery prac-
tice [7,8]. 
Multiple research groups around the world are actively investi-
gating questions related to adipose tissue and fat grafting. Before 
beginning human clinical research, preclinical translational stud-
ies must be completed. Ideally, methods used in in-vivo and in-
vitro studies should be consistent and systematic for compari-
son. Inconsistency in translational models makes the results dif-
ficult to evaluate, compare and correlate to the human condi-
tion. With regards to fat grafting, standardized universal models 
have not been established. Not only are scientists investigating 
questions about fat grafting but they are also investigating the 
methods that they are using to answer those questions. 
This paper compiles the current information available on fat 
grafting translational models as a systematic review. It aims to 
describe the differences and similarities between published 
studies and discuss future perspectives. 
METHODS 
A comprehensive PUBMED literature review was performed 
with the search terms “Fat Grafting” AND OR “Fat Graft” pub-
lished up to April 2015. Each article was screened based on the 
abstract content and selected if animal models were involved in 
the study. Then a secondary screening was performed. Only 
original research articles written in English language and related 
to fat grafting for soft tissue reconstruction and volume aug-
mentation were included. Review articles were excluded. 
Full articles meeting the inclusion criteria were carefully ana-
lyzed by 3 reviewers (J.L., R.A., and K.S.) to find commonali-
ties. Factors such as number of publications in the last few years, 
animal species used in these studies, type of graft (human xeno-
grafts, autograft, allograft, or other xenograft), duration of study 
until sacrifice (reported in weeks), method of volume quantifi-
cation, graft recipient site, grafting technique, and amount of in-
jection were collected. Data regarding harvesting and processing 
methods was not included in this review which was focused 
only on variables pertinent to the animal models used. 
Data was pooled and descriptive statistics were obtained from 
these results and illustrated in graphs (Fig. 1). 
RESULTS 
The search yielded 1,408 results published from years 1928 to 
2015 related to fat grafting. We then excluded in-vitro, clinical 
and review papers yielding to 202 results employing fat grafting 
for a variety of purposes. Of those, we found that only 100 pub-
lications were specifically oriented to volume restoration in ani-
mal models and were written in English Language. These arti-
cles were published between 1968–2015. We found a consistent 
increase in the number of publications per year in the last 15 
years, and a 9-fold increase when comparing years 2000 to 2014 
(Fig. 2). 
Animal models 
Results demonstrated that the animal model used most com-
monly was the mouse (56% of the studies). In descending order 
of popularity, the other species used were rats, rabbits, pigs and 
dogs (Fig. 3A). Within mice, 7 strains were used fairly consis-
tently, most of them with some level of immunocompromise. 
14% of the studies reported to use wild type (WT B6/C57) 
mice for studying allo- or autografts. From the immunosup-
Fig. 1. Pubmed literature search
A pubmed search was done using “Fat Grafting” AND OR “Fat Graft” 
key words. Inclusion criteria were studies using animals, articles 
written in English and articles that studied fat grafting used for 
volume restoration. In vitro, clinical studies and literature reviews 
were excluded, as well as papers not written in English and not re-
lated to volume retention. 100 Studies met our inclusion criteria 
and were obtained and carefully analyzed by 3 authors.
Pubmed search: “fat grafting” and or “fat graft”
1,408 Items
In vitro studies
Clinical studies
Reviews
Not in English
Not related to fat graft 
volume retention
202 Items
100 Animal studies
read in detail
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pressed strains, “Athymic Nude” was used more commonly 
(50%). These mice lack a thymus, and therefore have no mature 
T cells while still preserving the rest of the immune system. 4% 
of the studies used the NOD-SCID strain which have impaired 
B and T lymphocytes and deficient natural killer (NK) cells 
(Fig. 3B). 
Type of graft 
52% of the studies used autologous grafts (i.e., own inguinal fat 
pad to dorsum), versus 41% of studies performing xenografts 
using human fat. The rest did either allografts or other non-hu-
man xenografts (Fig. 4A). Subcutaneous dorsum was the most 
common recipient site (51%) with 28% grafting underneath the 
scalp. Intra-abdominal (12%) and head & neck (9%, cheeks, 
ears, neck) grafts were preferred by some studies (Fig. 4B). 
Characteristics of the grafts 
57% of studies reported injecting the graft in a single bolus tech-
nique, whereas 43% reported grafting in a fan-like pattern, dis-
tributing the graft in multiple passes using a single entry point 
underneath the skin (Fig. 5A). An average of 0.86 ± 0.60 mL of 
fat was grafted in the studies; however volume of the graft could 
range from 0.10 to 1.50 mL in a single procedure (Fig. 5B). 
 
Duration of study and volume quantification 
Study duration and time of follow-up of graft volume retention 
ranged from 1 to 52 weeks. Most studies had more than one 
time point of sacrifice. The most common end points were 4 
weeks (15%), 8 weeks (11%) and 12 weeks (19%). One third 
of the studies had sacrifice time between 8–12 weeks. 11% of 
studies lasted less than 1 week (Fig. 6). 
Quantification of fat graft was done by 3 main approaches: 
weight (63%) was the most popular modality and measured 
through a variety of scales. Some groups opted to use a pycnom-
eter, which utilizes changes in pressure, and volume in a gas 
chamber to assess the volume and density of an explanted fat 
graft. 25% of studies used histology to quantify fat retention 
through the use of stains such as H&E, Oil Red or Immunohis-
tochemistry. Quantification based on digital imaging modalities 
was used in a 12% of the studies, either by micro-computed 
tomo graphic (CT) scanning or MRI (Fig. 7). More than one 
quantification method was used in the majority of the studies. 
DISCUSSION 
Fat grafting is a common component in many plastic surgery 
procedures completed today. According to the ASPS annual re-
port, 67,609 procedures were performed in 2014 using fat as a 
Fig. 2. Publications related to fat grafting in the last years
Of the articles selected, we found an increasing trend of articles 
published related to fat grafting over the last few years, showing 
the growing interest of the medical community.
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Fig. 3. Breakdown of species utilized as well as mouse strain
A B
Rabbit
16%
Mouse
56%
Athymic 
nude
50%
Other
9%
Fox1-nu
5%
FVB
5%
WT
14%
CD-1 nude
56%
BALB/c-nu
7%
SCID
4%
Rat
20%
Dog
3%
Pig
5%
Species used Mice strain(A) Breakdown of species utilized 
more frequently. (B) Strain of 
mice more commonly selected. 
Lujan-Hernandez J et al. In-vivo models used in fat grafting research
364
Fig. 4. Grafts and recipient area in fat grafting studies
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abdominal
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xenograft
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Head &
Neck
9%
SQ scalp
28%
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52%
Type of graft Graft recipient area(A) Type of graft more commonly 
used in studies: autologous (i.e., 
same mouse’s groin to dorsum), 
human xenograft (i.e., human fat 
to mouse dorsum), other xeno-
graft (i.e., rat to mouse), or al-
lograft (i.e., mouse inguinal fat to 
another mouse’s dorsum). (B) 
Recipient areas most frequently 
used. SQ, subcutaneous.
Fig. 5. Technique for grafting and volume injected
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Fig. 6. Duration of studies
Overview of time-points used for sacrifice/volume quantification in studies.
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soft tissue filler [9]. The vast majority of plastic surgeons (85%), 
utilize fat grafting, which justifies the 2% overall increase from 
2013. In addition to cosmetic procedures, fat grafting is used in 
reconstructive procedures. Evidence supports an increasing 
prevalence of this technique across the spectrum of plastic sur-
gery [10]. 
When conducting translational studies, choosing the animal 
model is critical; It should match human characteristics as best 
as possible [11]. Mice are largely the most used model due to 
their extensive pedigree structure, large array of disease models, 
transgenic tools, knockout strains, and mouse-specific reagents 
[11]. Their skin shares some physiological similarities with hu-
mans, but also significant histological differences including the 
difference in thickness of epidermis and dermis, and the pres-
ence of the panniculus carnosus muscle between hypodermis 
and subcutaneous layer [12]. This is important as, in humans, 
superficial fat grafts are subdermal or subcutaneous. Due to the 
thin skin layers in mice, grafts are inevitably deposited in a deep-
er plane between the panniculus carnosus muscle and skeletal 
muscle. This same plane becomes a single unit and detaches 
from muscle once grafts are deposited, making it difficult for the 
graft to remain in the appropriate location and maintain shape. 
Pig and human skin share the most histological similarities 
[13], having equally thick epidermis and dermis (human skin: 
50–120 μm; pig skin: 30–140 μm). Pig’s skin is strongly adhered 
to underlying internal structures and lacks the panniculus car-
nosus that rodents have. Additionally, the size and orientation of 
blood vessels, keratin proteins and a lipid film at the pigs skin’s 
surface resemble human teguments. 
However high costs and special care are involved in pig usage 
($275–$1,321 each and $11 per housing/day) making mouse 
($87–$140 each and $0.70 per housing/day) and rat ($50–
$360 each and $0.70 per housing/day) models more popular. 
Therefore, should translational accuracy be jeopardized for eco-
nomic reasons? As a counterpoint, pigs offer the advantage of a 
larger surface area, where multiple experiments can be carried in 
one single pig, and skin with human-like characteristics that 
could mimic the clinical setting better [14]. 
Studies are divided between using allografts, autografts or xe-
nografts. Autografts avoid rejection problems while using ingui-
nal fat, although some authors consider this tissue to be a mix-
ture of brown-thermogenic fat and white-energy-storing adi-
pose tissue [15,16], which is known to have physiological differ-
ences compared to white subcutaneous fat [17]. On the other 
hand, xenografts utilize human tissue, but require a hindered 
immune system to avoid rejection, altering physiological vari-
ables that are not representative of a clinical setting. We found 
that few of the studies doing xenografts utilized non-immuno-
compromised animals, which was surprising for the authors as 
well, without giving a clear explanation to this phenomenon. It 
has been postulated that adipose tissue and adipose-derived 
stem cells have low immunogenicity. However this grants more 
research before doing xenografts in immunocompetent species. 
For now, finding a compromise between these approaches 
would be ideal. Perhaps an alternative could be doing autografts 
in a larger model where subcutaneous fat can be harvested by li-
posuction [18,19]. 
Recipient site for fat grafts varies widely amongst research 
groups. Some groups prefer grafting below the scalp of mice, ar-
guing that the lack of subcutaneous fat enables easier identifica-
tion and cleaner resection at the time of explant [20,21]. On the 
other hand, proponents of grafting in the subcutaneous dorsum 
believe that it provides a more robust vasculature between 2 
muscle layers (panniculus carnosus and the dorsal muscles) 
Fig. 7. Graft volume quantification 
A B
Histologic
25%
Imaging
12%
H&E
56%
Other
13%
IHC
26%
Oil red
5%
Weight
63%
Main method of graft quantification Quantification by histology(A) Main methods for volume 
quantification used by the stud-
ies. (B) Staining techniques used 
in histologic sections by studies. 
IHC, immunohistochemical.
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(Fig. 8) [22]. However, this may be more adventitious to fat 
graft survival when compared to the human situation. Graft sur-
vival requires a healthy perfusion of blood to ensure that vital 
oxygen diffusion occurs. The elasticity of skin and the resistance 
to expansion in response to an injection in a closed compart-
ment results in an increase in interstitial pressure (i.e., breast, 
face), which effects fat survival [23]. However, small animals 
have loose skin, which alleviates the pressure under the graft. 
This allows for higher graft survival in mouse models. There-
fore, in mice, more fat can be grafted in a bolus before reaching a 
critical pressure when compared to a similar amount in humans. 
There is divided opinion between “bolus injection” and “fan 
like pattern”. The latter might be more clinically translatable 
[22], however in our experience, the plane under the skin dis-
sected with the injection cannula may act as a single plane (Fig. 
8). This makes the fan pattern challenging. We believe that 
grafting in that way either makes the fat quantification difficult 
or the fat parcels coalesce under the plane where the graft is de-
posited (between panniculus carnosus and the dorsal muscles) 
[22], which defeats the purpose of grafting. Similarly, the graft is 
very mobile which is why, in our lab, we have opted for using ex-
ternal splints surrounding the grafts (Fig. 9). Regardless of the 
technique, we found that studies inject varying levels of fat vol-
ume (0.2–1.4 mL per graft). 
The ideal time to follow-up grafts before sacrifice also remains 
undetermined. We found studies can range from 1–52 weeks, 
although 1/3 of the articles believe the best window for sacrifice 
occurs between 8–12 weeks after the initial injection, once re-
modeling of the graft has occurred. This lack of standardization 
makes it difficult to compare studies to each other. Moreover, 
the evidence and the trend in the findings suggests that final 
changes in volume seem to stabilize after 8 weeks [20,24] for a 
significant time, making this time-point potentially the earliest 
most cost-effective approach. 
Fig. 8. Histologic location of grafts
Microscopic cross section of subcutaneous fat graft. Note the loca-
tion under the dermis, between panniculus carnosus and the dorsal 
muscles. Stained with Perilipin-A IHC staining (×4) and counter-
stained with Hematoxylin. IHC, immunohistochemical. 
Fig. 9. Splinting for graft protection 
A Rubber splint placed over the grafts for the first week post-injec-
tion to avoid migration and protect the graft from friction or self-
inflicted damage.
Fig. 10. Quantification with micro-CT scanning
Volume estimation using micro-
CT scanning for small animals. 
Axial view and 3D reconstruc-
tion after contouring in com-
puter software. CT, computed 
tomography. 
 
Paninculus
carnosus muscle
Dorsal muscle
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Different methods of quantification for final graft volume have 
been described. Weight estimation strategies are effective and 
have been used by the majority of the studies. Weight can be ob-
tained by resecting the fat pad at the time of sacrifice [25], and 
then weighing it on an electronic scale [26]. Some groups will 
wash, blot or dry the fat after resection [26]. Others use fluid 
(saline/water) displacement to measure the volume of the fat 
pad. Some groups have opted for using a sophisticated Pycnom-
eter [27] which measures volume and density of the fat pad in-
side a gas chamber. This device can cost around $11,462 ac-
cording to a distribution source. All these measuring techniques 
carry the risk of allowing for operator-dependent bias, as the 
weights are small and the scales are extremely sensitive. Small 
actions such as under-excision or over-excision of surrounding 
non-adipose tissue could severely skew the results. Additionally, 
they usually require the mouse to be sacrificed during the proce-
dure. 
Other imaging techniques such as micro-CT scanning can be 
a reliable way to obtain a 3D visualization of the graft and accu-
rate volume estimation without sacrificing the animal (Fig. 10) 
[20,24]. Not all facilities have access to an in-vivo CT scanning 
machine for small species and costs can be expensive (at our in-
stitution the fee per scan is $100). If the machine is not avail-
able, purchasing a micro-CT scanning machine can cost more 
than $370,000, plus maintenance fees and trained personnel. In 
our opinion, both techniques quantify only mass and are equal-
ly effective, although we favor CT scanning as we believe has 
less room for technical error. However cross sectional histology 
becomes indispensable to define what the tissue is and assess 
the presence of cysts, calcifications and graft viability, as weight 
or 3D image do not distinguish what is inside of the graft. 
Therefore we found that almost every study used histological 
analysis in addition to their volume or mass quantification. 
Some groups have opted for Hematoxylin and Eosin or Oil Red 
staining. Others have preferred immunohistochemical (IHC) 
Perilipin-A staining [28], which is a surface marker that is pres-
ent in live metabolically active adipocytes (Fig. 11). In our opin-
ion, Perilipin-A, is more technically challenging, but is more 
specific in detecting live adipocytes, in comparison to H&E or 
oil red, which stains all structures equally, regardless of their 
metabolic status. 
Our mouse model (Fig. 12). 
CONCLUSIONS
In conclusion, studies involving fat grafting research in animal 
models are heterogeneous. At this point in time, performing xe-
nografts from human fat on immunodeficient mice is the pre-
ferred animal model to assess volume retention of fat grafts. Al-
most all of the design parameters need to be standardized in or-
Fig. 11. Adipose tissue staining
Perilipin-A is a reliable way to stain live and metabolically active 
adipocytes using IHC on paraffin embedded sections (Perilipin-A, 
ICH staining, ×20). IHC, immunohistochemical. 
Perilipin-AIHC staining
Fig. 12. Evidence-based fat grafting model
Our mouse model based on our experience and the evidence col-
lected in the creation of this study. CT, computed tomographic; IHC, 
immunohistochemical. 
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der to achieve a systematic method and make results compara-
ble. To our knowledge, this is the first study that provides an 
overview of this topic. Moreover, at least theoretically, scaling 
up to larger animals should be the goal of future research in fat 
grafting in order to have better translatable results for human 
studies. We hope our work can help promoting dialogue among 
the adipocyte research community to establish agreed upon pa-
rameters for research. 
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